Innovative Compounding Pharmacy is voluntarily recalling several injectable prescription medications, including Methylcobalamin (B-12), MIC-8, Hydroxyprogesterone Caproate, Testosterone Cypionate, and a Tri-Mix solution (Alprostadil/Papaverine/Phentolamine). These products were recalled because the pharmacy cannot guarantee they are sterile, which is a critical safety requirement for any medication injected into the body. This recall affects specific lots distributed to patients in California, Maine, and Texas between November 2019 and March 2020.
Injecting a drug that is not sterile can introduce bacteria or other contaminants directly into the bloodstream or muscle tissue, which can lead to serious, life-threatening infections or localized abscesses. While no injuries have been reported to date, the lack of sterility assurance means the safety of these products cannot be confirmed.
Innovative Compounding Pharmacy refund and guidance.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.